Browsing Category
Pharma Industry News
4765 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Tvardi Therapeutics initiates REVERTIPF trial in idiopathic pulmonary fibrosis
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in the development of STAT3 inhibitors, has reached a significant…
Zydus Lifesciences bags FDA approval for Erythromycin Tablets
Zydus Lifesciences Limited, an Indian pharmaceutical company, has clinched final approval from the United States Food and Drug…
Biocon Generics acquires US facility for $7.7m, targets two billion tablet capacity
Biocon Limited, a global leader in the biopharmaceutical industry, has made a landmark announcement: its wholly-owned subsidiary, Biocon…
Zydus Lifesciences gains FDA approval for Acne treatment capsules
Zydus Lifesciences Limited has secured final approval from the US Food and Drug Administration (USFDA) for its Isotretinoin…
Novo Nordisk acquires Embark Biotech and enters R&D collaboration to advance obesity treatments
Novo Nordisk, a global leader in healthcare, has acquired Embark Biotech, including its lead metabolic program, in a…
Strides Pharma gets FDA nod for Mycophenolate Mofetil, targets $145m market
Strides Pharma Science Limited has announced a significant win as its Singapore-based wholly owned subsidiary, Strides Pharma Global…
Ajanta Pharma secures FDA approval for Topiramate Capsules, eyes 2026 market launch
Ajanta Pharma Limited, a leading specialty pharmaceutical formulation company, has won a decisive victory by gaining final approval…
Lupin Pharma Canada debuts Propranolol LA, filling gap left by Inderal LA
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited, has officially launched its Propranolol LA capsules in…
EC approves Pfizer’s ABRYSVO RSV vaccine for infants and older adults
Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for ABRYSVO, its bivalent respiratory syncytial…
BridgeBio Pharma’s Acoramidis Phase 3 trial in ATTR-CM hits primary endpoint
BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company specializing in genetic diseases and cancers, announced that the…